Annual Operating Expenses
$1.98 B
+$187.29 M+10.45%
December 31, 2022
Summary
- As of March 3, 2025, HZNP annual total operating expenses is $1.98 billion, with the most recent change of +$187.29 million (+10.45%) on December 31, 2022.
- During the last 3 years, HZNP annual operating expenses has risen by +$1.18 billion (+147.29%).
Performance
HZNP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$584.16 M
-$3.34 M-0.57%
June 30, 2023
Summary
- As of March 3, 2025, HZNP quarterly total operating expenses is $584.16 million, with the most recent change of -$3.34 million (-0.57%) on June 30, 2023.
- Over the past year, HZNP quarterly operating expenses has increased by +$82.69 million (+16.49%).
Performance
HZNP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
HZNP Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.4% | +16.5% |
| 3 y3 years | +147.3% | +92.5% |
| 5 y5 years | +124.9% | +190.7% |
HZNP Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -9.5% | -0.6% | -18.5% |
| 5 y | 5-year | at high | -59.6% | -0.6% | -63.4% |
| alltime | all time | at high | -99.1% | -0.6% | -99.3% |
Horizon Therapeutics Public Limited Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $584.16 M(-0.6%) |
| Mar 2023 | - | $587.50 M(+19.9%) |
| Dec 2022 | $1.98 B(+10.5%) | $490.06 M(-4.2%) |
| Sep 2022 | - | $511.62 M(+2.0%) |
| Jun 2022 | - | $501.47 M(+5.4%) |
| Mar 2022 | - | $475.87 M(-4.9%) |
| Dec 2021 | $1.79 B(+62.6%) | $500.20 M(+11.2%) |
| Sep 2021 | - | $449.81 M(-9.1%) |
| Jun 2021 | - | $495.04 M(+27.0%) |
| Mar 2021 | - | $389.69 M(+45.7%) |
| Dec 2020 | $1.10 B(+37.7%) | $267.47 M(+4.3%) |
| Sep 2020 | - | $256.37 M(-15.5%) |
| Jun 2020 | - | $303.40 M(+10.3%) |
| Mar 2020 | - | $274.98 M(+28.5%) |
| Dec 2019 | $800.28 M(+3.2%) | $213.95 M(+8.7%) |
| Sep 2019 | - | $196.90 M(+0.8%) |
| Jun 2019 | - | $195.41 M(+0.7%) |
| Mar 2019 | - | $194.02 M(-0.1%) |
| Dec 2018 | $775.25 M(-11.9%) | $194.31 M(+6.3%) |
| Sep 2018 | - | $182.75 M(-9.1%) |
| Jun 2018 | - | $200.94 M(+1.9%) |
| Mar 2018 | - | $197.24 M(-0.5%) |
| Dec 2017 | $880.05 M(+32.6%) | $198.29 M(+15.4%) |
| Sep 2017 | - | $171.88 M(-46.7%) |
| Jun 2017 | - | $322.75 M(+72.5%) |
| Mar 2017 | - | $187.13 M(-14.7%) |
| Dec 2016 | $663.75 M | $219.45 M(+51.5%) |
| Sep 2016 | - | $144.86 M(+0.1%) |
| Jun 2016 | - | $144.78 M(-6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $154.66 M(+11.3%) |
| Dec 2015 | $482.17 M(+112.7%) | $138.92 M(+16.2%) |
| Sep 2015 | - | $119.56 M(-17.1%) |
| Jun 2015 | - | $144.17 M(+81.3%) |
| Mar 2015 | - | $79.52 M(+27.9%) |
| Dec 2014 | $226.69 M(+121.7%) | $62.18 M(-15.3%) |
| Sep 2014 | - | $73.44 M(+51.9%) |
| Jun 2014 | - | $48.35 M(+13.2%) |
| Mar 2014 | - | $42.72 M(+39.7%) |
| Dec 2013 | $102.25 M(+19.1%) | $30.59 M(+29.3%) |
| Sep 2013 | - | $23.65 M(-3.6%) |
| Jun 2013 | - | $24.54 M(+4.6%) |
| Mar 2013 | - | $23.47 M(-5.5%) |
| Dec 2012 | $85.84 M(+69.4%) | $24.84 M(+15.9%) |
| Sep 2012 | - | $21.43 M(+10.8%) |
| Jun 2012 | - | $19.33 M(-4.5%) |
| Mar 2012 | - | $20.24 M(-4.0%) |
| Dec 2011 | $50.68 M(+21.0%) | $21.08 M(+43.6%) |
| Sep 2011 | - | $14.68 M(+84.0%) |
| Jun 2011 | - | $7.98 M(+14.9%) |
| Mar 2011 | - | $6.94 M(-38.0%) |
| Dec 2010 | $41.87 M(+122.8%) | $11.21 M(-3.0%) |
| Sep 2010 | - | $11.56 M(+0.6%) |
| Jun 2010 | - | $11.48 M(+50.7%) |
| Mar 2010 | - | $7.62 M(+43.2%) |
| Dec 2009 | $18.79 M(-30.1%) | $5.32 M(+18.0%) |
| Sep 2009 | - | $4.51 M(-5.6%) |
| Jun 2009 | - | $4.78 M(+14.2%) |
| Mar 2009 | - | $4.18 M |
| Dec 2008 | $26.87 M | - |
FAQ
- What is Horizon Therapeutics Public Limited annual total operating expenses?
- What is the all time high annual operating expenses for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited annual operating expenses year-on-year change?
- What is Horizon Therapeutics Public Limited quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly operating expenses year-on-year change?
What is Horizon Therapeutics Public Limited annual total operating expenses?
The current annual operating expenses of HZNP is $1.98 B
What is the all time high annual operating expenses for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual total operating expenses is $1.98 B
What is Horizon Therapeutics Public Limited annual operating expenses year-on-year change?
Over the past year, HZNP annual total operating expenses has changed by +$187.29 M (+10.45%)
What is Horizon Therapeutics Public Limited quarterly total operating expenses?
The current quarterly operating expenses of HZNP is $584.16 M
What is the all time high quarterly operating expenses for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly total operating expenses is $587.50 M
What is Horizon Therapeutics Public Limited quarterly operating expenses year-on-year change?
Over the past year, HZNP quarterly total operating expenses has changed by +$82.69 M (+16.49%)